Mitsubishi Tanabe Pharma Corporation

01/26/2024 | Press release | Distributed by Public on 01/25/2024 20:06

Mitsubishi Tanabe Pharma contribute funding to Global Health Innovative Technology Fund's third phase ―Targeting treatments for infectious diseases that burden the developing[...]